Replacement of the phosphodiester linkage in oligonucleotides by heterocycles: Synthesis of thymidine dinucleotide analogs with triazole-modified backbones

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 12, 1997, Pages 1549-1552

  Von Matt, Peter ^a   Lochmann, Thomas ^a   Altmann, Karl Heinz ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGODEOXYRIBONUCLEOTIDE; THYMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; DNA BINDING; DRUG SYNTHESIS; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RNA BINDING; STEREOCHEMISTRY;

EID: 0030927293     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00269-2     Document Type: Article

References (29)

1. Wendeborn, S.; Wolf, R. M.; De Mesmaeker, A. Tetrahedron Lett. 1995, 36, 6879.
2. (a) De Mesmaeker, A.; Lesueur, C.; Bévièrre, M.-O.; Waldner, A.; Fritsch, V.; Wolf, R. M. Angew. Chem. Int. Ed. Engl. 1996, 35, 2790.
3. (b) De Mesmaeker, A.; Waldner, A.; Lebreton, J.; Hoffmann, P.; Fritsch, V.; Wolf, R. M.; Freier, S. M. Angew. Chem. Int. Ed. Engl. 1994, 33, 226.
4. (c) Lebreton, J.; Waldner, A.; Lesueur, C.; De Mesmaeker, A. Synlett, 1994, 137.
5. 20 In addition, the cis amide conformer yielded a stable duplex structure in molecular dynamics computations. (equation presented)
6. 3′-Deoxy-3′-(1,2,3-triazol-1-yl)thymidines have been synthesized as potential anti-HIV agents. See, e.g. (a) Hirota, K.; Hosono, H.; Kitade, Y.; Maki, Y.; Chu, C. K.; Schinazi, R. F.; Hideo, N.; Ono, K. Chem. Pharm. Bull. 1990, 38, 2597.
7. (b) Häbich, D.; Barth, W. Heterocycles, 1989, 29, 2083.
8. (c) Wigerinck, P.; Van Aerschot, A.; Claes, P.; Balzarini, J.; De Clercq, E.; Herdewijn, P. J. Heterocyclic Chem. 1989, 26, 1635.
9. See also: (d) Lazrek, H. B.; Taoprirte, M.; Kabbaj, Y.; Oulih, T.; Barascut, J. L.; Imbach, J. L.; Almasoudi, N. A.; Pfleiderer, W. Abstract of Papers, XII IRT Nucleosides, Nucleotides And Their Biological Applications, La Jolla, CA, September 1996; PPI 27.
10. See: Saenger, W. Principles of Nucleic Acid Structure; Springer: New York, 1984.
11. 2 was synthesized by a similar strategy as reported in: Cao, X.; Matteucci, M. D. Tetrahedron Lett. 1994, 35, 2325.
12. Huang, J.; McElroy, E. B.; Widlanski, T. S. J. Org. Chem. 1994, 59, 3520.
13. Kozikowski, A. P.; Jiang-Ping W. Tetrahedron Lett. 1987, 28, 5125.
14. 2P(=O)-R) corresponding to 4; for a discussion, see ref 1.
15. Oikawa, Y.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 885.
16. Sinha, N. D.; Biernat, J.; McManus, J.; Köster, H. Nucleic Acids Res. 1984, 12, 4539.
17. (a) Hammerschmidt, F.; Polsterer, J.-P.; Zbiral, E. Synthesis 1995, 415.
18. (b) Zbiral, E. Synthesis 1974, 775.
19. Maillard, M.; Faraj, A.; Frappier, F.; Florent, J.-C.; Grierson, D. S.; Monneret, C. Tetrahedron Lett. 1989, 30, 1955.
20. (a) Broka, C. A.; Gerlits, J. F. J. Org. Chem. 1988, 53, 2144.
21. (b) Mirsadeghi, S.; Rickborn, B. J. Org. Chem. 1986, 51, 986.
22. Blanco, L.; Amice, P.; Conia, J. M. Synthesis 1976, 194.
23. Weihe, G. R.; McMorris, T. C. J. Org. Chem. 1978, 43, 3942.
24. Similar transylidations have recently been reported: (a) Lin, N-H.; Overman, L. E.; Rabinowitz, M. H.; Robinson, L. A.; Sharp, M. J.; Zablocki, J. J. Am. Chem. Soc. 1996, 118, 9062.
25. (b) Aitken, R. A.; Atherton, J. I. J. Chem. Soc. Perkin Trans. I 1994, 1281.
26. cf. Lin, T.-S.; Prusoff, W. H. J. Med. Chem. 1978, 21, 109.
27. Zammattio, F.; Brion, J. D.; Ducrey, P.; Le Baut, G. Synthesis 1992, 375.
28. (a) De Mesmaeker, A.; Lebreton, I.; Waldner, A.; Fritsch, V.; Wolf, R. M. Bioorg. Med. Chem. Lett. 1994, 4, 873.
29. (b) Lebreton, J.; De Mesmaeker, A.; Waldner, A.; Fritsch, V.; Wolf, R. M.; Freier, S. M. Tetrahedron Lett. 1993, 34, 6383.